Search results
31% of Australians are obese – is Ozempic a healthy solution? A GP considers Johann Hari’s inside...
The Conversation· 2 days agoObesity levels for adults have hit 26% in Britain and 42.5% in the United States, journalist Johann Hari writes in his new book, Magic Pill. Hari, who grew up eating “almost ...
11 Low-Fat Foods You Can Eat This Week To Lose Weight This Summer: Berries & More
SheFinds via Yahoo News· 5 days agoLow-fat foods are dietary options designed to minimize the intake of fats, particularly saturated...
Corbus Pharmaceuticals shares rally on raised price target, Outperform rating By Investing.com
Investing.com· 1 day agoOppenheimer has raised the price target on Corbus Pharmaceuticals (NASDAQ:CRBP) shares to $80 from...
Zepbound Can Help People with Multiple Conditions Lose Weight Safely
Healthline via AOL· 3 days agoThe main advantage of GLP-1s compared to previous treatments is that the rate of response is very...
Study finds more women in oil-rich Gulf countries battle with breast cancer
Medical Xpress· 20 hours agoThe study attributes the hike to the nature of menstrual cycle of women in these countries,...
'Govt must now focus on tackling emerging infectious diseases, NCDs'
Investing.com· 8 hours agoNew Delhi, June 4 (IANS) While India has made significant progress in the healthcare sector,...
How schools can help children eat well and be active
Medical Xpress· 4 days agoThe latest report by the Child of the North research group, which includes academics from the N8 Partnership universities, including the University of...
Structure Therapeutics reports promising weight-loss drug data | Invezz
Invezz· 19 hours agoStructure Therapeutics Inc (NASDAQ: GPCR) is up a whopping 80% on Monday after reporting “compelling” topline data for its weight-loss drug. The biopharmaceutical firm said its experimental ...
GLP-1 Coverage Often Denied for Teens With Obesity
Medscape· 2 days agoInsurance companies frequently deny insurance coverage of glucagon-like peptide-1 (GLP-1) receptor agonists for adolescents, according to a new analysis. For those whose GLP-1 prescriptions ...
The big business of obesity and shame
The Fayette Tribune· 5 days agoManufacturers of new weight loss drugs are salivating at the prospect of profit. What Americans eat, how they diet and exercise, the sugar content of...